David S Mcclellan, MD | |
101 W 8th Ave, Spokane, WA 99205-4805 | |
(509) 474-3131 | |
Not Available |
Full Name | David S Mcclellan |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 101 W 8th Ave, Spokane, Washington |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073535886 | NPI | - | NPPES |
8149163 | Medicaid | WA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | MD00021609 (Washington) | Primary |
Mailing Address | Practice Location Address |
---|---|
David S Mcclellan, MD Po Box 12229, Westminster, CA 92685-2229 Ph: (888) 432-2088 | David S Mcclellan, MD 101 W 8th Ave, Spokane, WA 99205-4805 Ph: (509) 474-3131 |
News Archive
There is a very good reason mothers often carry their crying babies, pacing the floor, to help them calm down. New research published in the Cell Press journal Current Biology on April 18 shows that infants experience an automatic calming reaction upon being carried, whether they are mouse or human babies.
A team of researchers in Europe has created a comprehensive data resource to help improve understanding of how coronavirus disease 2019 (COVID-19) progresses and how biomarkers could be used to guide treatment approaches and disease monitoring.
For nearly 13 years, Highmark Inc.'s People Able to Lend Support program has provided a wide array of programs and services to help seniors stay healthy and independent in their own homes, stimulate their minds and reduce isolation.
Breastfeeding affects infant growth and, researchers have found, helps prevent obesity, both in childhood and later in life. However, the components of breast milk responsible for these beneficial effects remain mostly a mystery.
Pharnext SAS, a biopharmaceutical company specializing in the development of innovative treatments for severe neurological diseases and other major unmet medical needs, today announced that the French Agency for Healthcare Product Safety (AFSSAPS) has authorized a Phase II clinical trial with the first drug (a Pleodrug™) generated by the company's Pleotherapy™ technology platform in patients suffering from Charcot-Marie Tooth disease type 1A (CMT1A.
› Verified 9 days ago
Dr. Richard W Walker, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-484-8069 Fax: 509-462-4086 | |
Lynn Bergman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood, Emergency Physicians Services, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
Mary Anna Chiu, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5633 N Lidgerwood St, Spokane, WA 99208 Phone: 509-482-2448 Fax: 509-482-2452 | |
Charles N. Roberts, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 5633 N. Lidergerwood, Spokane, WA 99208 Phone: 509-482-0111 | |
Stephen Penaskovic, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 | |
Michael J Wymore, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 101 W 8th Ave, Spokane, WA 99205 Phone: 509-474-3131 |